@article{a6e9d0bb3ad24c96835bc2ef5eaf2264,
title = "RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer",
abstract = " The dynamic cell–cell communication is essential for tissue homeostasis in normal physiological circumstances and contributes to a diversified tumor microenvironment. Although exosomes are extracellular vesicles that actively participate in cell–cell interaction by shutting cellular components, impacts of tumor exosomes in the context of cancer stemness remain elusive. Here, we expand colorectal cancer stem cells (CRCSCs) as cancer spheroids and demonstrate that the β-catenin/Tcf-4-activated RAB27B expression is required for the secretion of CRCSC exosomes. In an exosomal RNA sequencing analysis, a switch of exosomal RNA species from retrotransposons to microRNAs (miRNAs) is identified upon expanding CRCSCs. miRNA-146a-5p (miR-146a) is the major miRNA in CRCSC exosomes and exosomal miR-146a promotes stem-like properties and tumorigenicity by targeting Numb in recipient CRC cells. Among 53 CRC patients, those with abundant exosomal miR-146a expression in serum exhibits higher miR-146a High /Numb Low CRCSC traits, an increased number of tumor-filtrating CD66(+) neutrophils and a decreased number of tumor-infiltrating CD8(+) T cells. Our study elucidates a unique mechanism of tumor exosome-mediated stemness expansion. ",
keywords = "cancer stem cells, exosome heterogeneity, microRNA biomarker",
author = "Cheng, {Wei Chung} and Liao, {Tsai Tsen} and Lin, {Chun Chi} and Yuan, {Lan Ting Emily} and Lan, {Hsin Yi} and Lin, {Hung Hsin} and Teng, {Hao Wei} and Chang, {Hsin Chuan} and Lin, {Chi Hung} and Yang, {Chih Yung} and Huang, {Shih Ching} and Jiang, {Jeng Kai} and Yang, {Shung Haur} and Yang, {Muh Hwa} and Hwang, {Wei Lun}",
note = "Funding Information: The authors would like to dedicate this article to the memory of Prof. Hsei-Wei Wang (Institute of Microbiology and Immunology, National Yang-Ming University), who passed away during the period of this research. This paper could not have been completed without his long-lasting devotion to bioinformatics and colon cancer research. We would like to express our appreciation for the assistance of the Biobank at Taipei Veterans General Hospital for human specimens. We would like to thank the University of South Carolina and Dr. Boris Kantor (Department of Neurobiology, School of Medicine, Duke University) for providing pBK176 and pBK109 for the IDLV-CRISPR/Cas9 system. We thank Dr. Amy Pei-Ching Chang (Institute of Microbiology and Immunology) for providing native secondary antibody during revision. This work was supported by the Cancer Progression Research Center, National Yang-Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. This work is supported by Taipei Medical University (TMU104-AE1-B11 to W-L.H), Yuan{\textquoteright}s General Hospital (106YGH-TMU-02 to W-L.H) and China Medical University (CMU106-N-05 and CMU107-S-24 to W-C.C.), Ministry of Science and Technology (105-2320-B-038-009-MY2; 106-2628-B-010-005-MY3 to W-L.H., 108-2636-B-010-005 to T-T.L. and 106-2221-E-039-011-MY3 to W-C.C.), and a grant from Ministry of Health and Welfare, Center of Excellence for Cancer Research (MOHW107-TDU-B-211–114019 to M-H.Y.). Funding Information: The authors would like to dedicate this article to the memory of Prof. Hsei-Wei Wang (Institute of Microbiology and Immunology, National Yang-Ming University), who passed away during the period of this research. This paper could not have been completed without his long-lasting devotion to bioinformatics and colon cancer research. We would like to express our appreciation for the assistance of the Biobank at Taipei Veterans General Hospital for human specimens. We would like to thank the University of South Carolina and Dr. Boris Kantor (Department of Neurobiology, School of Medicine, Duke University) for providing pBK176 and pBK109 for the IDLV-CRISPR/Cas9 system. We thank Dr. Amy Pei-Ching Chang (Institute of Microbiology and Immunology) for providing native secondary antibody during revision. This work was supported by the Cancer Progression Research Center, National Yang-Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. This work is supported by Taipei Medical University (TMU104-AE1-B11 to W-L.H), Yuan's General Hospital (106YGH-TMU-02 to W-L.H) and China Medical University (CMU106-N-05 and CMU107-S-24 to W-C.C.), Ministry of Science and Technology (105-2320-B-038-009-MY2; 106-2628-B-010-005-MY3 to W-L.H., 108-2636-B-010-005 to T-T.L. and 106-2221-E-039-011-MY3 to W-C.C.), and a grant from Ministry of Health and Welfare, Center of Excellence for Cancer Research (MOHW107-TDU-B-211?114019 to M-H.Y.). Publisher Copyright: {\textcopyright} 2019 UICC",
year = "2019",
month = jan,
day = "1",
doi = "10.1002/ijc.32338",
language = "English",
volume = "145",
pages = "2209--2224",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",
}